Graziano T. et al. The possible innovative use of Bifidobacterium longum W11 in association with rifaximin: a new horizon for combined approach? J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S153-S156.
Inturri R. et al. Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain. Genome Announc. 2017 Mar 9;5(10). pii: e01659-16. doi: 10.1128/genome A.01659-16.
Inturri R. et al. Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum, Carbohydrate polymers / Elsevier 2017.
Medina et al. Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications, Clinical and Experimental Immunology, 2007.
Izquierdo E. et al. Resistance to Simulated Gastrointestinal Conditions and Adhesion to Mucus as Probiotic Criteria for B. longum strains. Curr Microbiol 2008, 56:613-618.
Interri R. et al. Scanning Electro Microscopy Observation of Adhesion Properties of B. longum W11 and Chromatographic Analysis of Its Exopolysaccharide 2014, Food and Nutrition Sciences 1787-1792.
Interri R. et al. Immunomodulatory Effects of B. longum W11 Produced Exopolysaccharide on Cytokine Production. 2017, Current Pharmaceutical Biotechnology.
B. longum W11, an antibiotic resistant probiotic, Di Pierro 2018, CEC online article: http://ceceditore.com/bifidobacterium-longum-w11-anantibiotic-resistant-probiotic/?lang=en.